Clinical Trials
15 trialsNCT06279143 2026-05-26
dOCT-pBCC
Vejle Hospital
Completed
NCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT06039137 2024-09-25
H1-Switch
Erasmus Medical Center
Completed
NCT03917147 2023-04-12
Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination
University of Campania Luigi Vanvitelli
Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT00831571 2022-04-18
Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin
Dana-Farber Cancer Institute
Completed
NCT04907422 2021-09-01
Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours
October 6 University
Completed
NCT03270215 2020-12-17
The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion
Naestved Hospital
Completed
NCT03272997 2020-12-17
The Value of PET-CT in Pleural Effusions
Naestved Hospital
Completed
NCT03847753 2020-05-22
COMO-GMC
University of Aarhus
Completed
NCT03406325 2020-04-09
Mast Cell Activation Test in Allergic Disease
Hong Kong Sanatorium & Hospital
Completed
NCT03858738 2019-03-04
A Pilot Study on Use of Liquid Crystal Contact Thermography to Detect Early Breast Cancer
Braster S.A.
Completed
NCT01436617 2013-03-08
IgES
Centre Francois Baclesse
Completed